Lowering drug doses for dialysis. (Treatment News).
Researchers from Duke University Medical Center in North Carolina have reported that HIV-infected patients with end-stage kidney disease requiring chronic dialysis can be given much lower doses of the anti-HIV drug Epivir. A once-daily dose of 25 mg in dialysis patients provided the same amount
In addition, make sure to read these articles:
- Data Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and...
- First Controlled Safety Study Suggests That T-20, in Combination With Oral Antiretrovirals,...
- Drugs for GI upset may interact with HIV protease inhibitors.
- Man who received baboon liver in 1992 became infected with baboon CMV.
- Biosynexus' New Anti-microbial Agent Destroys MRSA Biofilm; Only Compound Shown to be...
- Methadone adjustment with Viramune.
- Enanta Pharmaceuticals Presents Macrolide and Ketolide Antibiotic Data in 12 Poster...
- Gilead and Roche Begin Phase II/III Studies of anExperimental Product to Treat or Prevent...
- PowderMed's DNA-Based Flu Vaccine Shows Cross-Protective Immunity against...
- Optimer Presents Positive Data on Two Lead Anti-Infective Drug Candidates.
- Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug...
- Ecopia Presents Three Posters on its Antibacterial Agent ECO-0501 at the 44th Annual ICAAC.
- Enanta Pharmaceuticals Presents Macrolide Antibiotic Research at the Annual 42nd...
- PolyMedix to Present Data on Novel Antibiotics under Development at the 46th Annual ICAAC.
- Optimer to Present Data on Lead Antibiotic Candidates at ICAAC.
WILMINGTON, Del. -- Incyte Corporation (Nasdaq:INCY) announced today that four scientific posters have been presented at the 47th Annual Interscience Conference on Antimicrobial Agents ......
Business Editors/Health & Medical Writers DURHAM, N.C. & NUTLEY, N.J--(BW HealthWire)--Feb. 12, 2001 First Results for T-20 In Moderately Treatment-Experienced Patients Are Among Data Presented ......
According to a study presented at the 7th International Congress on Drug Therapy in HIV Infection in Glasgow, Scotland (abstract 206), many HIV+ people suffer ......
A man who received a baboon liver in 1992 quickly became infected with baboon cytomegalovirus (CMV), a virus thought to be species-specific. "This is the ......
Health/Medical Writers BIOWIRE2K GAITHERSBURG, Md.--(BUSINESS WIRE)--Oct. 30, 2003 Biosynexus Incorporated, a privately held biotechnology-pharmaceutical company, today announced that it has demonstrated the efficacy of one ......
Patients taking methadone as part of a drug detox program who are also taking the HIV reed Viramune may need to adjust their dose of ......
Business Editors/Health/Medical Writers BIOWIRE2K CHICAGO--(BUSINESS WIRE)--Sept. 15, 2003 Data Includes Product Profiles of Lead Compounds Effective Against Resistant Organisms and Targeted for Treatment of Respiratory ......
FOSTER CITY, Calif.--(BW HealthWire)--Dec. 16, 1997-- Eligible Volunteers Can Enroll by Calling 888/I-GOT-FLU Gilead Sciences, Inc. (NASDAQ:GILD) and Hoffmann-La Roche Inc. announced today the start ......
WASHINGTON & OXFORD, United Kingdom -- Results of Phase 1 Clinical Trial Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Since ......
Prulifloxacin Shown to be More Active than Standard of Care SAN DIEGO -- Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR), presented data on the activity of its ......
Selzentry Now Available Throughout the U.S. for Use in Combination Therapy for Certain Treatment-Experienced HIV Patients CHICAGO -- Nearly three times as many patients ......
MONTREAL -- Ecopia BioSciences Inc. (TSX:EIA) presented data on ECO-0501 in the form of three posters yesterday at the 44th annual Interscience Conference on Antimicrobial ......
Business Editors/Health & Medical Writers BIOWIRE2K SAN DIEGO--(BUSINESS WIRE)--Sept. 30, 2002 Enanta Pharmaceuticals Inc. (www.enanta.com), a leading drug discovery company that focuses on morphing existing ......
PHILADELPHIA -- PolyMedix, Inc. (OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, ......
SAN DIEGO -- Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR), today announced that results of a microbiologic study on the in vitro activity of OPT-80 and its ......
Email
Digg It
del.icio.us
Related Resources
Press Releases
- Data Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Demonstrate That INCB9471 is a Potent, Selective Inhibitor of the HIV-1 Virus with Excellent Pharmacokinetics...
- First Controlled Safety Study Suggests That T-20, in Combination With Oral Antiretrovirals, Reduces Viral Load Below Limit of Detection in More Patients Than Oral Regimen Alone.
- Trimeris and Roche Report Clinical Progress inDevelopment of HIV Fusion Inhibitors.
Business Resources
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© Copyright 2008 The Gale Group, Inc. All rights reserved.
© Copyright © 2002 The Center for AIDS: Hope & Remembrance Project
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
© Copyright © 2002 The Center for AIDS: Hope & Remembrance Project
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
